Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00827099 · FLOW

Participant flow

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer · Source last updated 2012-03-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    1. Fludarabine 30 mg\^m2 on days -7, -6, -5, -4 \& -3 2. Melphalan 140 mg\^m2 on day -2 3. Rabbit antithymocyte globulin (ATG) 6mg/kg divided over 3 days, Days -4,-3,-2. (Thymoglobulin 1.0mg/kg on day -4, and 2.5mg/kg/d on days -3, -2) 4. Tacrolimus starting on day -1 as a continuous infusion of 0.03 mg/kg/d. 5. Mycophenolate mofetil (MMF) IV 15mg/kg BID will start on Day 0
    id
    FG000
    title
    Umbilical Cord Blood Transplantation
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        5
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        5
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
There were no group assignments for this study. It was a single arm cord blood transplant study.
recruitment Details
Study was IRB approved on 6/8/06. The first patient was enrolled on 6/9/06. The last patient was enrolled on 12/22/08.
Complete source fields
groups
  1. description
    1. Fludarabine 30 mg\^m2 on days -7, -6, -5, -4 \& -3 2. Melphalan 140 mg\^m2 on day -2 3. Rabbit antithymocyte globulin (ATG) 6mg/kg divided over 3 days, Days -4,-3,-2. (Thymoglobulin 1.0mg/kg on day -4, and 2.5mg/kg/d on days -3, -2) 4. Tacrolimus starting on day -1 as a continuous infusion of 0.03 mg/kg/d. 5. Mycophenolate mofetil (MMF) IV 15mg/kg BID will start on Day 0
    id
    FG000
    title
    Umbilical Cord Blood Transplantation
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        5
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        5
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
There were no group assignments for this study. It was a single arm cord blood transplant study.
recruitment Details
Study was IRB approved on 6/8/06. The first patient was enrolled on 6/9/06. The last patient was enrolled on 12/22/08.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice